2-(2-Methylaminoethyl)Pyridine
CAS: 5638-76-6
Ref. 3D-FM52866
1g | Discontinued | ||
2g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
25g | Discontinued |
Product Information
- Methyl-(2-pyridin-2-yl-ethyl)amine
- (2-(2-Pyridyl)ethyl)methylamine
- 2-(2-(Methylamino)ethyl)pyridine
- 2-(β-Methylaminoethyl)pyridine
- 2-Pyridineethanamine, N-methyl-
- Betahistina
- Betahistina [INN-Spanish]
- Betahistine
- Betahistine [INN:BAN]
- Betahistinum
- See more synonyms
- Betahistinum [INN-Latin]
- Betaistina
- Betaistina [DCIT]
- Brn 0112294
- Methyl(2-pyridin-2-ylethyl)amine
- N-Methyl-2-(2-pyridinyl)ethanamine
- N-Methyl-2-(2-pyridyl)ethylamine
- N-Methyl-2-pyridineethanamine
- N-Methyl-2-pyridineethylamine
- N-Methyl-N-[2-(2-pyridinyl)ethyl]amine
- N-Methyl-N-[2-(pyridin-2-yl)ethyl]amine
- N-Methyl-N-beta-(2-pyridyl)ethylamine
- N-Methyl[2-(pyridin-2-yl)ethyl]amine
- N-[2-(2-Pyridyl)ethyl]-N-methylamine
- Nsc 42617
- Obe 101
- PT 9 base
- Pyridine, 2-(2-(methylamino)ethyl)-
- Pyridine, 2-(2-methylaminoethyl)-
- Serc base
- Sinmenier (free base)
- Unii-X32Kk4201D
- Vasomotal
- Y-G 14
- beta-Histine
- β-Histine
2-(2-Methylaminoethyl)Pyridine is a chemical substance that has been shown to have significant effects on the central nervous system. It has been investigated as a potential treatment for metabolic disorders, such as obesity and diabetes, and allergic symptoms. 2-(2-Methylaminoethyl)Pyridine also has locomotor activity-enhancing properties, which may be due to its ability to bind to receptors in the brain. 2-(2-Methylaminoethyl)Pyridine is available as an injection solution. It is not known whether this drug would be beneficial for geriatric patients or people with vestibular disorders.